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Arsenic in drinking water is a major public 
health problem in the Bengal delta, affecting 
millions of people in the West Bengal state of 
India and adjoining areas in Bangladesh. In 
view of widespread poor nutrition prevalent in 
West Bengal and Bangladesh, it is important to 
identify dietary factors that might increase arse-
nic toxicity or metabolism. We have already 
reported on the relationship of dietary constit-
uents and blood micronutrients with arsenic-
caused skin lesions in West Bengal (Chung 
et al. 2006; Mitra et al. 2004). Here, we report 
the findings concerning 19 dietary intake con-
stituents, 16 blood micronutrients, and urine 
creatinine with arsenic methylation patterns 
in urine, in what we believe is the first com-
prehensive joint assessment of dietary intake 
and micronutrients. For brevity, we refer to 
the dietary intake factors, along with the blood 
micronutrients, as “nutritional factors.”
Nutritional factors may play important 
roles in methylation of inorganic arsenic 
(InAs), and the results of numerous studies 
have shown that methylation affects the toxicity 
of ingested InAs. In drinking water, InAs exists 
in trivalent [As(III)] and pentavalent [As(V)] 
forms. After ingestion, As(V) is reduced to 
As(III), followed by sequential methylation 
and reduction reaction steps resulting in for-
mation of trivalent and penta valent methylated 
arsenicals—first monomethyl acids [MMA(III) 
and MMA(V)] and subsequently trivalent and 
pentavalent  dimethyl acids [DMA(III) and 
DMA(V), respectively. However, this process 
is incomplete, and populations show variations 
in the proportions of urinary InAs and the 
methylated arsenical compounds (Aposhian 
1997; Concha et al. 2002; Drobna et al. 
2004; Healy et al. 1997; Hopenhayn-Rich 
et al. 1996a, 1996b; Hopenhayn et al. 2003; 
Hughes 2002).
Isolat ion and character izat ion of 
MMA(III) indicates that the first step of 
methylation that produces MMA should be 
considered an activation step. Laboratory 
studies have shown that the trivalent forms of 
MMA and DMA are much more toxic than 
the pentavalent forms, and in vitro evidence 
suggests that MMA(III), in particular, may 
be more toxic than trivalent InAs [InAs(III)] 
(Cullen and Reimer 1989; Lin et al. 1999, 
2001; Mass et al. 2001; Petrick et al. 
2000; Styblo et al. 1999, 2000; Styblo and 
Thomas 1997). The conversion of MMA(III) 
to DMA(V) in a second methylation step 
then reduces toxicity. Epidemiological stud-
ies have found evidence of increased risks of 
skin and bladder cancer among persons with 
higher proportions of MMA in their urine 
(Steinmaus et al. 2003). Therefore, factors 
that influence arsenic methylation may be 
important determinants of susceptibility to 
health effects resulting from exposure to InAs 
in drinking water. We were also interested 
in urine creatinine, because it is frequently 
used to adjust for the concentration of urine, 
something that would introduce bias if creati-
nine were related to arsenic methylation.
Methods
Study participants. This study involved 
405 participants selected from a study base 
of 7,683 individuals living in the South 
24-Parganas district of West Bengal, India, 
who were identified in a 1995 through 1996 
cross-sectional survey (Guha Mazumder et al. 
1998). Participants had been selected for a 
case–control study of skin lesions caused by 
arsenic involving 192 cases and 213 controls 
(Haque et al. 2003), whose primary sources 
of drinking water contained < 500 µg/L InAs 
[n = 4,185 (2,160 females and 2,025 males)].
Cases had positive skin-lesion classifica-
tions, with either hyperpigmentation (mot-
tled, dark-brown pigmentation bilaterally 
distributed on the trunk), keratoses (diffuse 
thickening of palms or soles, with or with-
out nodules), or both conditions at the time 
of the survey. Of the 7,683 individuals in 
the base population, we randomly selected 
controls from a subset of 4,185 individuals, 
with drinking water concentrations of arsenic 
< 500 µg/L; controls were matched to cases 
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Background: Ingested inorganic arsenic (InAs) is methylated to monomethylated (MMA) and 
dimethylated metabolites (DMA). Methylation may have an important role in arsenic toxicity, 
because the monomethylated trivalent metabolite [MMA(III)] is highly toxic.
oBjectives: We assessed the relationship of creatinine and nutrition—using dietary intake and 
blood concentrations of micronutrients—with arsenic metabolism, as reflected in the proportions 
of InAS, MMA, and DMA in urine, in the first study that incorporated both dietary and micro­
nutrient data.
Methods: We studied methylation patterns and nutritional factors in 405 persons who were 
selected from a cross­sectional survey of 7,638 people in an arsenic­exposed population in West 
Bengal, India. We assessed associations of urine creatinine and nutritional factors (19 dietary intake 
variables and 16 blood micronutrients) with arsenic metabolites in urine.
results: Urinary creatinine had the strongest relationship with overall arsenic methylation to 
DMA. Those with the highest urinary creatinine concentrations had 7.2% more arsenic as DMA 
compared with those with low creatinine (p < 0.001). Animal fat intake had the strongest relation­
ship with MMA% (highest tertile animal fat intake had 2.3% more arsenic as MMA, p < 0.001). 
Low serum selenium and low folate were also associated with increased MMA%.
conclusions: Urine creatinine concentration was the strongest biological marker of arsenic 
methylation efficiency, and therefore should not be used to adjust for urine concentration in arsenic 
studies. The new finding that animal fat intake has a positive relationship with MMA% warrants 
further assessment in other studies. Increased MMA% was also associated, to a lesser extent, with 
low serum selenium and folate.
key words: arsenic, creatinine, diet, India, methylation, micronutrients, West Bengal. Environ 
Health Perspect 119:1308–1313 (2011). http://dx.doi.org/10.1289/ehp.1003393 [Online 7 June 
2011]
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by sex and by age within 4 years. The study 
protocol was approved by the institutional 
review boards of the Institute of Post Graduate 
Medical Education and Research, Kolkata, 
India, and the University of California–
Berkeley, Berkeley, California. Informed 
 consent was obtained from all participants.
In this investigation, we assessed dietary 
intake and measured blood micronutrients 
and methylated arsenic species in urine sam-
ples for pooled cases and controls. Cases with 
skin lesions were included after adjusting for 
possible distortion of associations between the 
nutritional factors and arsenic methylation 
patterns by including an indicator variable for 
skin lesions in the analyses.
In India, socioeconomic status is com-
monly measured by type of dwelling, which 
is correlated with household economic status 
(Mishra et al. 1999). In this study, we deter-
mined socioeconomic status based on the 
materials used to construct the house where the 
respondent lived. We considered three types of 
houses: pucca houses, built with high-quality 
materials such as bricks or concrete; semipucca 
houses, constructed partly with clay and bricks; 
and kacha (mud houses). We classified educa-
tional status as nonformal (participant never 
attended school), primary education (up to 
4 years of education), high school education 
(between 8 and 12 years of education), and 
beyond high school education or tertiary edu-
cation (> 12 years of formal education).
Assessment of dietary intake and blood 
micronutrients. We ascertained food intake 
for each participant with a detailed question-
naire based primarily on 24-hr recall. The 
methods used for dietary assessment have 
been described elsewhere (Mitra et al. 2004). 
In brief, the most senior woman, who in this 
population directed the preparation of food 
for the family, was interviewed and ques-
tioned about each meal from lunch the previ-
ous day through breakfast on the day of the 
interview. The volume of each cooked food 
was assessed by asking the senior woman to 
estimate these volumes using standard cups 
and plates. Standard-sized spoons were used 
to assess the intake of sugar and oil. We asked 
about weekly consumptions of meat, fish, 
eggs, milk, and fruit, because these items were 
not typically consumed on a daily basis. The 
1-week intake of these food items was then 
divided by 7 to compute the mean intake per 
day. We calculated total 24-hr intake of the 
following nutrients using a spreadsheet pro-
gram based on food composition tables (listed 
here in alphabetical order): animal fat, ani-
mal protein, calcium, carbohydrate, carotene, 
fiber, folate, iron, niacin, phosphorus, retinol, 
thiamin, vegetable fat, vegetable protein, vita-
min B6, vitamin B12, vitamin C, and zinc 
(Mitra et al. 2004). We adjusted each dietary 
variable for individual total calorie intake by 
dividing total daily dietary intake by total 
calorie intake.
Field team physicians interviewed partici-
pants using a structured questionnaire, con-
ducted a general examination, and obtained 
blood samples from each participant when they 
were visited in their homes. We have previously 
presented detailed information concerning 
storage and analysis of blood samples (Chung 
et al. 2006). In brief, non fasting blood samples 
were collected and stored in an ice chest in the 
field. Aliquots were prepared within 24 hr, 
frozen at –20°C in India, and later transported 
to the United States on dry ice, where they 
were stored at –70°C until laboratory analysis. 
Pacific Biometrics (Seattle, WA, USA) con-
ducted most of the serum and plasma analyses 
for the micronutrients and biochemical indica-
tors or in some instances arranged for them to 
be done at a different laboratory. Plasma mea-
surements included homocysteine, glutathi-
one, cysteine, methionine, vitamin B6, retinol 
(vitamin A), alpha-tocopherol (vitamin E), 
alpha-carotene, beta-carotene, lycopene, lutein-
zeaxanthin, and beta-cryptoxanthine (Chung 
et al. 2006). Serum measurements included 
glucose, cholesterol, vitamin B12 (cobalamin), 
folate, transthyretin, and selenium.
Measurement of urinary arsenic and cre-
atinine. Because urine is the primary route 
of arsenic excretion, the proportions of the 
various arsenic metabolites in urine are com-
monly used as an indicator of the degree to 
which a person can methylate ingested InAs 
(National Research Council 2001). Spot urine 
samples were collected from each participant 
and stored frozen for later analysis at the Trace 
Organics Analysis Laboratory (University of 
Washington, Department of Environmental 
and Occupational Health Sciences, Seattle, 
Washington). The urinary concentrations of 
arsenic were measured using hydride genera-
tion/cryogenic concentration, atomic fluo-
rescence detection, using an Excalibur AFS 
detector (PS Analytical, Inc., Deerfield 
Beach, FL). In this technique, InAs, MMA, 
and DMA were reduced to the correspond-
ing arsine in a batch reactor, using sodium 
borohydride in 5-mL samples. The volatile 
reduction products (arsenic, methyl arsine, 
and dimethyl arsine) were removed by sparging 
with helium. Entrained arsines were concen-
trated in a  chromosorb-filled cryogenic trap at 
liquid nitrogen temperatures until all arsine-
forming arsenic in the sample had reacted. The 
cryotrap was then allowed to warm, and the 
collected arsines were separated on the basis of 
differential volatilization. The separated vola-
tile arsenic species were detected with a hydro-
gen microburner combustion cell to convert 
arsines to elemental arsenic. To prevent inter-
ference by other compounds, each urine sam-
ple was acidified with 2 M HCl and allowed to 
sit for at least 4 hr prior to speciation analysis. 
Total arsenic was determined by atomic fluo-
rescence spectrometry with flow injection 
analysis (Excalibur AFS, PS Analytical) on 
a portion of the urine sample that had been 
mineralized with hydrochloric acid and per-
oxide; the result was compared with the sum 
of the species detected. If a significant amount 
of arsenic remained undetected, additional 
digestion or assay for arsenobetaine was per-
formed. Detection limits for InAs, MMA, and 
DMA were 0.5, 1, and 2 µg/L, respectively. 
Concentrations below the detection limit 
were set at one-half the detection limit. The 
methods detected both oxidation states for 
each form of arsenic (inorganic, monomethyl, 
 dimethyl) and provided a single result for each 
methylation level. Urinary arsenic concentra-
tions were measured in micrograms per liter 
of urine; percentages of InAs (InAs%), MMA 
(MMA%), and DMA (DMA%) were calcu-
lated using the sum of arsenic species detected 
as the denominators. The creatinine concentra-
tions in urine were determined kinetically by a 
clinical autoanalyzer using the Jaffe  reaction 
(Larsen 1972).
Statistical methods. The relationships 
between demographic variables and urinary 
arsenic methylation patterns were first assessed 
in simple stratified analyses. Nutritional factors 
and urine creatinine were divided into tertiles, 
and we compared arsenic methylation patterns 
in the highest tertile of each factor with pat-
terns in the lowest tertile. We conducted t-tests 
of the differences in mean urinary InAs% 
between the highest and lowest tertiles of each 
nutritional factor. Nutritional factors were 
then ranked, starting with the nutritional fac-
tor associated with the largest absolute mean 
difference in InAs% between its highest and 
lowest tertiles. Nutritional variables with the 
highest mean differences were then entered 
into a series of multiple linear regression analy-
ses, as explained below. This series of steps was 
repeated for MMA% and DMA%.
In the multiple linear regression models, 
InAs%, MMA%, and DMA% were treated 
as response variables, and tertiles of selected 
dietary or micronutrient variables were the 
main explanatory variables. The lowest tertile 
of the dietary or micronutrient variable was 
treated as the reference category, and dummy 
variables were created for the middle and high-
est tertile for each nutritional variable. We used 
step-up methods, starting with the strongest 
predictors found in the univariate analyses. The 
beta coefficients corresponding to the highest 
tertile of the diet or micronutrient gives an 
effect measure of the potential impact of each 
nutrient on the specific urinary methylated 
arsenical. For example, a beta coefficient of –5 
in the model of InAs% for a particular nutri-
ent would indicate 5% difference (e.g., 20% 
InAs% for the high tertile compared with 25% 
InAs% for the low tertile), with adjustment for 
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the effect of all other variables specified in the 
model. This represents the independent effect 
of the nutrient on the specified urinary methy-
lated arsenical. In addition to nutritional fac-
tors, the other variables in the model were age, 
sex, housing, education, presence or absence 
of skin lesions, body mass index (BMI), and 
total urinary arsenic. Housing and education 
were modeled as categorical variables, whereas 
age, BMI, and urinary arsenic were modeled as 
continuous variables.
The important advantages of using tertiles 
of nutritional factors in the analyses, rather 
than continuous variables, include the fact 
that there is no implicit assumption about 
the functional form of any dose–response 
relationship. In addition, outliers often have 
undue influence on regression analyses, and 
dividing into tertiles avoids this problem, as 
outliers are merely one member of the tertile 
to which they belong. However, we repeated 
the analyses that produced the key findings 
using continuous variable regression and 
obtained similar results. p-Values were based 
on chi-square tests of trend for the following 
ordinal variables: categories of age, education, 
type of housing, urinary arsenic, and BMI 
(Table 1).
Results
The distribution of participants according to 
age, sex, education, and quality of housing 
is shown in Table 1. Men had lower urinary 
InAs% (men, 22.2%; women, 24.5%; p = 
0.05) and higher MMA% than did women 
(men, 8.9%; women, 7.0%; p = 0.01). Those 
with arsenic-caused skin lesions had lower 
urinary InAs% (21.2% vs. 24.7% for those 
without skin lesions; p = 0.02), and higher 
urinary DMA% (70.4% vs. 67.2%; p = 0.03). 
Table 2 presents the mean ± SD of the dietary 
factors intake per day and the mean concen-
trations of blood micronutrients.
The differences in mean urinary InAs%, 
MMA%, and DMA% between those in the 
highest and lowest tertiles of each dietary 
intake factor and blood micronutrient are 
presented in Table 3, ranked in order of the 
magnitude of the absolute differences, exclud-
ing those factors having a p-value > 0.2. The 
largest difference in urinary InAs% was for 
urinary creatinine, with those in the high-
est tertile of creatinine having 19.8 InAs% 
compared with those in the lowest tertile, 
who had 27.7% (difference 7.8%; p ≤ 0.001). 
Those in the highest tertile of plasma lyco-
pene also had lower InAs% (20.5% compared 
with 26.3%; p = 0.01). The largest differ-
ences in MMA% were for dietary animal fat, 
plasma retinol, plasma homocysteine, dietary 
retinol, and dietary animal protein, followed 
by serum folate and urinary creatinine, all of 
which were associated with p-values < 0.01. 
The largest difference (2.3%) was for ani-
mal fat (p < 0.001). When we repeated the 
analysis with animal fat as a continuous vari-
able, the result was the same (p < 0.001). The 
strongest association with DMA% was for 
urine creatinine, with those in the highest ter-
tile of creatinine having a DMA% of 71.4% 
compared with those in the lowest tertile, 
Table 1. Distribution of the percentage of urinary total arsenic in inorganic form (InAs%), monomethylated 
(MMA%), and dimethylated (DMA%), according to other factors for the 405 participants.
Characteristics n (%) InAs% MMA% DMA%
Age (years)
< 15 28 (6.9) 20.4 6.8 72.8
15–29 91 (22.5) 23.3 8.4 68.3
30–44 135 (33.4) 23.6 8.3 68.1
45–59 89 (21.9) 24.8 7.9 67.3
≥ 60 62 (15.3) 19.5 9.3 71.2
pa 0.19 0.06 0.14
Sex
Female 154 (38.2) 24.5 7.0 68.5
Male 251 (61.8) 22.2 8.9 68.9
pb 0.05 0.01 0.2
Education
Nonformal 117 (28.9) 22.5 8.2 69.3
Primary 200 (49.5) 23.5 8.2 68.3
Secondary 68 (16.8) 22.8 8.0 69.2
Tertiary 20 (4.9) 22.4 8.3 69.3
pa 0.47 0.48 0.46
House type
Kacha 205 (50.6) 22.6 8.3 69.1
Semipucca 138 (34.1) 24.1 7.9 68.1
Pucca 58 (14.3) 22.3 8.5 69.2
Missing data 4 (0.9)
pa 0.32 0.25 0.4
Skin lesions
Present 213 (52.5) 21.2 8.3 70.4
Absent 192 (47.4) 24.7 8.1 67.2
pb 0.02 0.56 0.03
BMI
< 16.9 122 (30.1) 23.5 8.0 68.5
16.9–19.3 121 (29.8) 21.3 8.7 70.1
> 19.3 126 (31.1) 22.2 8.4 69.4
Missing 36 (8.9)
pa 0.52 0.42 0.73
Total urinary arsenic (µg/L)
< 14.9 134 (33.1) 20.4 8.5 71.1
14.9–56.3 133 (32.8) 22.5 7.8 69.6
> 56.3 138 (34.1) 21.5 8.5 69.9
pa  0.55 0.48 0.71
ap-Value from test for trend. bp-Value from t-test.
Table 2. Mean intake per day of dietary factors, 
mean plasma and serum concentrations of micro-
nutrients, and mean urine creatinine concentra-
tions, with SDs for the 405 participants.
Dietary intake/micronutrient 
 concentration Mean ± SD
Diet survey
Calcium (mg/day) 484 ± 332
Carbohydrate (g/day) 448 ± 161
Carotene (µg/day) 3,546 ± 7,161
Energy (kJ/day) 9,204 ± 3,091
Fat, animal (g/day) 3.91 ± 4.24
Fat, vegetable (g/day) 21.8 ± 14.9
Fiber (g/day) 5.3 ± 3.47
Folate (µg/day) 164 ± 102
Iron (mg/day) 13.9 ± 7.0
Niacin (mg/day) 22 ± 8.1
Phosphorus (mg/day) 1,130 ± 435
Protein, animal (g/day) 9.7 ± 7.14
Protein, vegetable (g/day) 45 ± 17.1
Retinol (µg/day) 52.2 ± 66.1
Riboflavin (mg/day) 0.6 ± 0.3
Thiamin (mg/day) 1.49 ± 0.6
Vitamin B6 (mg/day) 1.3 ± 0.5
Vitamin C (mg/day) 111 ± 115
Zinc (mg/day) 9.2 ± 3.3
Plasma analysis
Alphatocopherol (µg/dL) 636 ± 214
Beta-carotene (µg/dL) 83.6 ± 97.3
Beta-cryptoxanthine (µg/dL) 5.74 ± 5.6
Homocysteine (µM/L) 14.8 ± 8.1
Lutein-zeaxanthine (µg/dL) 66.5 ± 30.6
Lycopene (µg/dL) 3.3 ± 4.9
Methionine (µM/L) 19.4 ± 5.7
Retinol (µM/dL) 34.1 ± 10.9
Transthyretin (mg/L) 237 ± 53.1
Vitamin B6 (nmol/L) 40.8 ± 45.3
Serum analysis
Cholesterol (mg/dL) 155 ± 35.4
Cysteine (µM/L) 215 ± 37.5
Folate (ng/mL) 3.4 ± 2.8
Selenium (µM/L) 1.2 ± 0.4
Total glutathione (µM/L) 6.3 ± 5.6
Vitamin B12 (pg/mL) 435 ± 315
Urine
Urine creatinine (mg/L) 622 ± 531.8
Diet, micronutrients, and arsenic methylation
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who had DMA% of 64.2% (difference 7.2%; 
p < 0.001). When we repeated the analysis 
with urine creatinine as a continuous variable, 
the p-value was the same (< 0.001).
The results of the multivariate analysis are 
presented in Table 4, using step-up methods 
to explore the findings. Covariates included 
in all models were age, sex, housing, educa-
tion, skin lesion status, total urinary arsenic, 
and BMI. The first model for InAs (InAs1) 
included creatinine and lycopene. In the uni-
variate analysis (Table 3), high creatinine was 
associated with a lower InAs%, with a differ-
ence of 7.8%. With the covariates and lyco-
pene in the model, the size of this difference 
is reduced from 7.8% to 4.6%, and lycopene 
becomes the more important variable both in 
terms of the difference in magnitude (4.9%) 
and p-values (0.03 vs. 0.08, Table 4). The 
association with creatinine was further reduced 
when riboflavin was added to the model.
Table 4 also presents five models 
(MMA1–MMA5) for MMA. In the univari-
ate analysis, there were eight factors that had 
strong relationships with MMA% (p ≤ 0.02). 
In the multivariate models, animal fat remains 
important in all models, with high animal fat 
intake related to a high MMA%. To a lesser 
extent, high plasma retinol was also associated 
with high MMA%, whereas high serum sele-
nium was associated with a lower MMA%. 
Two DMA models are given in Table 4; the 
strongest relationship was with urinary creati-
nine, with a high urine creatinine being asso-
ciated with a high DMA%.
Discussion
Diet and arsenic methylation, and blood 
micronutrients and arsenic methylation, have 
previously been assessed separately (Hall et al. 
2009; Heck et al. 2007, 2009; Huang et al. 
2009; Steinmaus et al. 2005). We believe 
this is the first comprehensive study of arse-
nic methylation including both dietary and 
micronutrient variables, along with urinary 
creatinine, considered together in the same 
analysis. New findings to emerge from this 
work include the fact that urinary creatinine 
was the strongest predictor of DMA%, with 
a high urinary creatinine being associated 
with more InAs being fully methylated to 
DMA. Once urinary creatinine was taken into 
account, no nutritional factor was a significant 
predictor of DMA%. A high urinary creatinine 
was associated in the opposite direction with 
InAs%, which had a lower percentage in urine 
when creatinine was high. This association for 
InAs% decreased when lycopene and ribo-
flavin were included in the model, with lyco-
pene becoming the strongest predictor variable 
in that a high lycopene concentration was 
associated with a low InAs%. One previous 
study suggested that low plasma lycopene was 
associated with reduced arsenic methylation 
Table 3. Association between dietary variables, serum levels of micronutrients, and urinary creatinine as 
assessed by comparing the mean arsenic metabolite percent between the lowest (T1) and highest (T3) 
tertiles of each factor.
Metabolite Nutritional factor T1 T3 Difference p-Valuea
InAs% Urine creatinine 27.7 19.8 –7.8 0.001
Plasma lycopene 26.3 20.5 –5.9 0.01
Dietary riboflavin 20.9 25.2 4.3 0.04
Serum selenium 19.6 23.7 4.1 0.03
Serum folate 20.4 24.3 3.9 0.04
Plasma vitamin B6 23.5 20.4 –3.1 0.14
Dietary calcium 23.0 25.9 2.9 0.19
Plasma lutein-zeaxanthine 23.9 21.0 –2.9 0.14
MMA% Dietary animal fat 7.0 9.3 2.3 0.001
Plasma retinol 7.3 9.2 1.9 0.001
Plasma homocysteine 7.3 9.2 1.9 0.002
Dietary retinol 7.3 9.1 1.8 0.004
Dietary animal protein 7.0 8.7 1.7 0.003
Serum folate 9.6 8.0 –1.7 0.007
Urine creatinine 7.2 8.7 1.5 0.004
Serum selenium 9.2 7.7 –1.5 0.02
Plasma alpha-tocopherol 8.0 9.1 1.1 0.07
Plasma beta-cryptoxanthine 7.3 8.4 1.1 0.07
Plasma vitamin B6 7.7 8.7 1.0 0.11
Plasma methionine 7.8 8.8 0.9 0.11
Dietary phosphorus 7.3 8.1 0.9 0.15
Dietary carbohydrate 8.6 7.8 –0.8 0.15
DMA% Urine creatinine 64.2 71.4 7.2 0.001
Dietary riboflavin 70.5 65.9 –4.6 0.03
Plasma lycopene 65.4 69.6 4.3 0.07
Plasma lutein-zeaxanthine 65.9 69.9 4.0 0.06
The table is limited to variables with p < 0.20. 
ap-Value from the t-test of the mean difference.
Table 4. Results of multivariate analysis of nutritional factors measured in diet (d), plasma (p), serum (s), 
and urine (u) with indicators of arsenic methylation InAs%, MMA%, and DMA%. The beta coefficients 
are for the highest tertile of each nutritional factor with the lowest tertile as the reference category.
Model Nutritional factor
Beta 
 coefficient 
Lower 
CI limit
Upper 
CI limit p-Value
InAs% models
InAs1 Creatinine (u) –4.6 –11.0 1.8 0.08
Lycopene (p) –4.9 –9.4 –0.4 0.03
InAs2 Creatinine (u) –4.1 –9.0 0.8 0.14
Lycopene (p) –6.2 –11.2 –1.2 0.02
Riboflavin (d) 5.9 0.9 10.9 0.02
InAs3 Creatinine (u) –3.4 –8.0 1.2 0.20
Lycopene (p) –5.3 –10.2 –0.4 0.04
Riboflavin (d) 4.6 –0.4 9.6 0.07
Selenium (s) 2.5 –2.6 7.6 0.35
MMA% models
MMA1 Animal fat (d) 2.0 0.8 3.3 0.003
Retinol (p) 1.8 0.5 3.1 0.005
MMA2 Animal fat (d) 1.9 0.6 3.2 0.01
Retinol (p) 1.7 0.4 3.1 0.02
Homocysteine (p) 1.9 0.6 3.3 0.01
MMA3 Animal fat (d) 1.9 0.5 3.3 0.003
Retinol (p) 1.6 0.2 3.0 0.03
Homocysteine (p) 1.1 –0.4 2.6 0.14
Folate (s) –2.1 –3.6 –0.6 0.03
MMA4 Animal fat (d) 2.3 0.9 3.7 0.001
Retinol (p) 2.1 0.7 3.5 0.002
Selenium (s) –2.2 –3.6 –0.8 0.001
MMA5 Animal fat (d) 2.5 1.1 3.9 0.001
Retinol (p) 2.0 0.6 3.4 0.006
Folate (s) –1.1 –2.6 0.4 0.15
Selenium (s) –2.3 –3.8 –0.9 0.002
DMA% models
DMA1 Creatinine (u) 5.4 0.3 10.5 0.04
Riboflavin (d) –3.3 –8.0 1.4 0.17
DMA2 Creatinine (u) 5.7 0.2 11.2 0.04
Riboflavin (d) –3.8 –8.9 1.3 0.15
Lycopene (p) 3.9 –1.2 9.0 0.13
Covariates in all models were age (continuous variable), sex, housing, education, skin lesion status, total urinary  arsenic 
(as a continuous variable), and BMI (as a continuous variable).
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capacity (Hsueh et al. 2009). However, as can 
be seen in Table 4, we find that full methyla-
tion to DMA was more strongly related to 
urinary creatinine than to lycopene.
The relationship between creatinine and 
arsenic methylation has been reported previ-
ously as an aside, without noting that it is the 
most important predictor nor being able to 
compare it with multiple nutritional factors as 
we have done here. In the past, urinary crea-
tinine has usually been used to normalize for 
urine concentration, to compensate for varia-
tion in diuresis. However, problems with doing 
so have been identified (Barr et al. 2005), in 
particular for studies of arsenic (Nermell et al. 
2008; Steinmaus et al. 2009). Gamble et al. 
reported a strong correlation between urinary 
creatinine and DMA% (p < 0.001) (Gamble 
et al. 2005), and Nermell et al. (2008) noted 
that urinary creatinine was correlated mainly 
with DMA. One recent study found that low 
urinary creatinine was associated with arsenic-
induced skin lesions (Pilsner et al. 2009). It is 
noteworthy that the formation of creatinine 
from methylation of guanidinoacetate accounts 
for approximately 75% of all folate-dependent 
transmethylation reactions (Barr et al. 2005; 
Mudd and Poole 1975).
Another new finding was that animal fat 
in the diet was by far the strongest predictor 
of MMA%, with a high intake of animal fat 
being associated with a high MMA%. Some 
investigators have thought that a high MMA% 
would be due to an increase in the first step of 
methylation from InAs% to MMA. However, 
because 85% of InAs, on average, is methy-
lated, at least to MMA, and the large majority 
ends up as DMA, increases in MMA% are 
more likely due to a reduction in the second 
step of methylation from MMA to DMA. We 
do not know why a high intake of animal fat 
would reduce the second step of methylation 
from MMA to DMA. One possibility is that 
animal fat intake is related to some unknown 
confounding factor. The only published study 
we could find that mentioned fat intake and 
methylation was a study of 66 adults who 
were kept on a fixed diet (Poirier et al. 2001). 
The investigators reported that during the 
experimental period of the study, when dietary 
fat intake was higher than during the usual 
diet, blood S-adenosylmethionine levels were 
inversely correlated with fat intake. The posi-
tive association between dietary animal fat 
and MMA% is a new finding not reported 
elsewhere. In a study on dietary intake and 
arsenic methylation based on a U.S. popula-
tion (n = 30), Steinmaus et al. (2005) did not 
find any relationship between fat intake and 
MMA% in urine. A possible reason why our 
findings were different from the U.S. study 
could be attributed to the different levels and 
patterns of nutrition between a U.S. popula-
tion and this rural Indian population.
The inverse association between serum 
folate and selenium and MMA% is supported 
by findings from other epidemiological studies. 
Using data from a cross-sectional survey in a 
comparable Bangladeshi population (n = 300), 
Gamble et al. reported that serum folate was 
inversely associated with InAs% (Spearman 
r = –0.12; p < 0.05) and MMA% (r = –0.12; 
p = 0.04) and was positively associated with 
serum homocysteine (r = 0.21; p < 0.05) and 
urinary DMA% (r = 0.21; p < 0.001) (Gamble 
et al. 2005). Gamble and colleagues reported 
univariate correlation estimates of associations 
and did not report results of multivariate asso-
ciations after adjustment of possible confound-
ing variables. On the same population, Gamble 
et al. (2005) conducted a follow-up double-
blind randomized controlled trial (n = 200) that 
compared 12-week administrations of folate 
versus placebo and found that after 12 weeks of 
folic acid supplementation, the increase in the 
proportion of total urinary arsenic excreted as 
DMA in the folate group (72% at baseline and 
79% after supplementation; p < 0.0001) was 
greater than that in the placebo group, as was 
the reduction in the proportions of total uri-
nary arsenic excreted as MMA (13% and 10%, 
respectively; p < 0.0001) and as InAs (15% and 
11%, respectively; p < 0.001). However, in this 
study, the intervention group and the placebo 
group were exposed to arsenic during the time 
of the trial (Gamble et al. 2006). Because this 
study was conducted among individuals con-
comitantly exposed to high concentrations of 
InAs, it cannot be inferred that folate supple-
mentation would benefit individuals who were 
no longer exposed to arsenic in drinking water.
Studies have consistently reported higher 
MMA% in males than in females (National 
Research Council 1999). In the univari-
ate comparison, the difference in MMA% 
between men and women was 1.9 (Table 1). 
This difference was not much less than for 
animal fat (2.3, Table 3). The difference 
between males and females may be explained 
in part by differences in animal fat intake and 
by differences in urinary creatinine.
Associations that might have been expected 
but were largely absent include homocysteine, 
vitamin B12 (cobalamin), and methionine. 
Homocysteine was strongly related to MMA% 
in univariate analysis, but the association 
became weaker in multivariate modeling when 
folate was added (Table 4). Heck et al. 2007 
reported a relationship between cobalamin and 
increased MMA to InAs ratio, but we found 
no evidence of it in this study (MMA% for 
the lowest tertile of vitamin B12 = 8.0 and for 
the highest tertile MMA% = 8.1; p = 0.75).
Data for this study came from a cross-
sectional survey. Information on the dietary 
variables was collected at the same time as 
blood was sampled for estimation of serum 
micronutrients, and urine was collected for 
estimation of urinary InAs%, MMA%, and 
DMA%. This provides a snapshot of inter-
relationships between diet, micronutrients, 
and arsenic methylation variables. Usually, the 
main limitation of cross-sectional studies per-
tains to inferring long-term outcomes from 
data obtained at one point in time. However, 
this limitation does not apply here, because it is 
reasonable to believe that arsenic methylation 
patterns would relate to current nutritional 
factors. In addition, it has been found that 
arsenic methylation efficiency in individuals is 
relatively stable over time (Concha et al. 2002). 
Another limitation is that because we did not 
have measures of urinary specific gravity, it was 
not possible to adjust for urine concentration. 
Our findings and those of others indicate that 
one should not use urinary creatinine to adjust 
for urine concentration in studies of arsenic, 
especially those involving speciation. However, 
it should be noted that the parameters of inter-
est in this study were InAs%, MMA%, and 
DMA%. The proportion of arsenic in these 
various forms is unlikely to be related to urine 
concentration, even though the concentrations 
in absolute terms would be.
Conclusions
This study revealed that urinary creatinine in 
the highest versus lowest tertile had a stron-
ger association with arsenic methylation to 
DMA than did similar contrasts for any of the 
dietary or micronutrient factors assessed. This 
finding provides further evidence that urinary 
creatinine should not be used to adjust urine 
concentrations for diuresis effects. Further 
studies are needed to investigate the determi-
nants of urine creatinine concentrations in 
arsenic-exposed populations, because such fac-
tors are also likely to influence arsenic methy-
lation. The new findings that plasma lycopene 
had an inverse relationship with InAs% and 
that animal fat intake had a positive relation-
ship with MMA% are new and warrant fur-
ther assessment in other studies.
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